Willis Towers Watson appoints Mike Liss to lead Corporate Risk and Broking in North America
Jan 18, 2017 14:05 pm UTC| Business
ARLINGTON, Va., Jan. 18, 2017 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, today announced the appointment of Mike Liss as head of its Corporate Risk and Broking (CRB)...
Minerals Technologies Inc. Declares Quarterly Dividend
Jan 18, 2017 14:02 pm UTC| Business
NEW YORK, Jan. 18, 2017 -- Minerals Technologies Inc. (NYSE:MTX) today declared a regular quarterly dividend of $0.05 per share on the company’s common stock. The dividend is payable on March 9, 2017 to stockholders of...
Jan 18, 2017 14:02 pm UTC| Business
VANCOUVER, British Columbia, Jan. 18, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) / (FKT:1MG) / (OTC:MGXMF) is pleased to provide additional details from the Company’s recent extraction of lithium from...
Merger Mines Corporation Signs Agreement with Groundhog Mining and Milling, LLC
Jan 18, 2017 14:02 pm UTC| Business
COEUR D’ALENE, Idaho, Jan. 18, 2017 -- Merger Mines Corporation of Coeur d’Alene, Idaho is pleased to announce that it has signed an agreement with Groundhog Mining and Milling, LLC of Dillon, Montana to form a working...
American Airlines Introduces New Basic Economy Fare
Jan 18, 2017 14:01 pm UTC| Business
FORT WORTH, Texas, Jan. 18, 2017 -- American Airlines (Nasdaq:AAL) today announced it will begin selling Basic Economy fares in addition to the wide range of Main Cabin fares currently offered. These no-frills tickets...
American Airlines Introduces New Basic Economy Fare
Jan 18, 2017 14:01 pm UTC| Business
FORT WORTH, Texas, Jan. 18, 2017 -- American Airlines (Nasdaq:AAL) today announced it will begin selling Basic Economy fares in addition to the wide range of Main Cabin fares currently offered. These no-frills tickets...
Immunomedics Announces New Data for IMMU-132 at Investor R&D Day
Jan 18, 2017 14:01 pm UTC| Business
-- IMMU-132 Provides Opportunity for Significant Near-Term Value Creation -- -- Submission for Accelerated Approval Application to FDA for Patients with Metastatic TNBC Remains on Track for mid-2017 -- -- Company...